Back to top
more

Better trading starts here.

Brokerage Reports

Research for DCTH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Delcath Systems, Inc. [DCTH]

Reports for Purchase

Showing records 101 - 120 ( 150 total )

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 101

10/12/2012

Daily Note

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of October 14

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 102

10/05/2012

Industry Report

Pages: 5

LIFE SCIENCES - The Week Ahead in Life Sciences - Upcoming Events for the Week of October 7

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 103

10/05/2012

Daily Note

Pages: 4

Expect FDA''s Initial Response to NDA Soon

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 104

09/28/2012

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of September 30.

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 105

09/20/2012

Daily Note

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of September 23

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 106

09/10/2012

Industry Report

Pages: 44

September 2012 Potential Catalysts & Milestones - Monthly Update

Provider: WEDBUSH SECURITIES INC.

Price: 100.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 107

08/31/2012

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of September 2, 2012

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 108

08/10/2012

Industry Report

Pages: 5

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 109

08/07/2012

Daily Note

Pages: 7

NDA Submission a Matter of Days, w/ Gen 2; Europe Building; Buy

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 110

08/07/2012

Company Report

Pages: 5

Q2:12 EPS, Chemosat First Sales in Europe, US NDA Re- Submission on Track for Mid-August, Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 111

07/27/2012

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of July 29

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 112

07/06/2012

Industry Report

Pages: 8

Healthcare - 2Q 2012: Quarterly Medical Technology Trading & Acquisition Valuation Update

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 113

06/18/2012

Daily Note

Pages: 12

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 114

06/06/2012

Daily Note

Pages: 8

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 115

06/06/2012

Company Report

Pages: 8

ASCO Update - Positive Physician Commentary; Adjusting Model for Funding

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 116

06/05/2012

Industry Report

Pages: 40

June 2012 Potential Catalysts & Milestones - Monthly Update

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 117

06/05/2012

Company Report

Pages: 7

ASCO Analyst Day Takeaways - CHEMOSAT Regional Therapy to Extend Life by Years; NDA Submission on Track for Aug 2012 - REITERATE OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 118

05/18/2012

Industry Report

Pages: 3

Med Tech Earnings Wrap-Up: What Looks Good Out of 1Q12

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 119

05/09/2012

Daily Note

Pages: 25

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 75.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 120

05/09/2012

Company Report

Pages: 7

NDA Submission Now Mid-August; Euro Experience Positive

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party